 |
 |

Adjuvant Chemotherapy for Breast CancerA Pooled Estimate Based on Published Randomized Control Trials
Harvey N. Himel, MD, MPH;
Alessandro Liberati, MD;
Richard D. Gelber, PhD;
Thomas C. Chalmers, MD
JAMA. 1986;256(9):1148-1159.
Abstract
The use of adjuvant chemotherapy for treating patients with operable breast cancer remains a worldwide controversy. Using the data from published randomized control trials with a minimum two-year follow-up, pooled estimates of relapse-free survival rates and overall survival rates were calculated. Relapse-free survival rates were improved by 12.5% (95% confidence interval [CI] ±4.5%) at three years and by 8% (CI ±6%) at five years, with studies using multiple agents showing a greater effect. A significant advantage was also present in overall survival rates at three years, but only for studies involving multiple agents (4% ±3.5%). Results from combining data for other types of trials were inconclusive. The use of this method is presented to illustrate its value as an explicit and systematic one for combining data from several randomized control trials in assessing a therapeutic controversy.
(JAMA 1986;256:1148-1159)
Author Affiliations
From the Departments of Health Policy & Management (Drs Himel and Chalmers), Epidemiology (Dr Liberati), and Biostatistics (Dr Gelber), Harvard School of Public Health, Boston; the Department of Biostatistics, Dana-Farber Cancer Institute (Dr Gelber), Boston; and the Clinical Trials Unit, Mount Sinai School of Medicine, New York (Dr Chalmers).
Footnotes
Reprint requests to Mount Sinai School of Medicine, 1 Gustave L. Levy Place, New York, NY 10029 (Dr Chalmers).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
A Review of Mortality From Choroidal Melanoma: II. A Meta-Analysis of 5-Year Mortality Rates Following Enucleation, 1966 Through 1988
Diener-West et al.
Arch Ophthalmol 1992;110:245-250.
ABSTRACT
Meta-analysis: A Quantitative Approach to Research Integration
Thacker
JAMA 1988;259:1685-1689.
ABSTRACT
|